vs
Side-by-side financial comparison of BRINKS CO (BCO) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× BRINKS CO). BRINKS CO runs the higher net margin — 4.9% vs 4.4%, a 0.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 9.1%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 5.6%).
The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
BCO vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $68.1M | $66.5M |
| Gross Margin | 27.7% | 90.5% |
| Operating Margin | 13.1% | 12.4% |
| Net Margin | 4.9% | 4.4% |
| Revenue YoY | 9.1% | 32.8% |
| Net Profit YoY | 76.9% | 143.8% |
| EPS (diluted) | $1.62 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $1.0B | ||
| Q2 24 | $1.3B | $929.2M | ||
| Q1 24 | $1.2B | $751.7M |
| Q4 25 | $68.1M | $66.5M | ||
| Q3 25 | $36.3M | $124.8M | ||
| Q2 25 | $43.7M | $94.3M | ||
| Q1 25 | $51.6M | $1.3M | ||
| Q4 24 | $38.5M | $-151.9M | ||
| Q3 24 | $28.9M | $-121.3M | ||
| Q2 24 | $46.2M | $-120.4M | ||
| Q1 24 | $49.3M | $-251.2M |
| Q4 25 | 27.7% | 90.5% | ||
| Q3 25 | 25.8% | 86.1% | ||
| Q2 25 | 24.9% | 87.5% | ||
| Q1 25 | 24.6% | 85.2% | ||
| Q4 24 | 26.1% | 85.8% | ||
| Q3 24 | 25.0% | 83.0% | ||
| Q2 24 | 25.2% | 85.1% | ||
| Q1 24 | 25.0% | 83.4% |
| Q4 25 | 13.1% | 12.4% | ||
| Q3 25 | 11.4% | 11.5% | ||
| Q2 25 | 10.3% | 6.7% | ||
| Q1 25 | 9.6% | 1.0% | ||
| Q4 24 | 8.3% | -7.0% | ||
| Q3 24 | 8.9% | -12.0% | ||
| Q2 24 | 9.3% | -11.5% | ||
| Q1 24 | 9.8% | -34.8% |
| Q4 25 | 4.9% | 4.4% | ||
| Q3 25 | 2.7% | 8.8% | ||
| Q2 25 | 3.4% | 7.2% | ||
| Q1 25 | 4.1% | 0.1% | ||
| Q4 24 | 3.0% | -13.5% | ||
| Q3 24 | 2.3% | -12.1% | ||
| Q2 24 | 3.7% | -13.0% | ||
| Q1 24 | 4.0% | -33.4% |
| Q4 25 | $1.62 | $0.05 | ||
| Q3 25 | $0.86 | $0.08 | ||
| Q2 25 | $1.03 | $0.06 | ||
| Q1 25 | $1.18 | $0.00 | ||
| Q4 24 | $0.87 | $-0.10 | ||
| Q3 24 | $0.65 | $-0.09 | ||
| Q2 24 | $1.02 | $-0.09 | ||
| Q1 24 | $1.09 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $4.5B |
| Total DebtLower is stronger | $4.0B | $836.4M |
| Stockholders' EquityBook value | $277.7M | $4.4B |
| Total Assets | $7.3B | $8.2B |
| Debt / EquityLower = less leverage | 14.31× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $4.5B | ||
| Q3 25 | $1.3B | $4.0B | ||
| Q2 25 | $1.4B | $2.8B | ||
| Q1 25 | $1.2B | $2.5B | ||
| Q4 24 | $1.4B | $2.6B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.2B | $2.6B | ||
| Q1 24 | $1.1B | $2.8B |
| Q4 25 | $4.0B | $836.4M | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.7B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.4B | — |
| Q4 25 | $277.7M | $4.4B | ||
| Q3 25 | $268.5M | $4.1B | ||
| Q2 25 | $254.6M | $3.8B | ||
| Q1 25 | $205.8M | $3.5B | ||
| Q4 24 | $184.9M | $3.3B | ||
| Q3 24 | $277.1M | $3.4B | ||
| Q2 24 | $320.5M | $3.4B | ||
| Q1 24 | $396.4M | $3.4B |
| Q4 25 | $7.3B | $8.2B | ||
| Q3 25 | $7.0B | $7.6B | ||
| Q2 25 | $7.1B | $6.3B | ||
| Q1 25 | $6.6B | $5.8B | ||
| Q4 24 | $6.6B | $5.9B | ||
| Q3 24 | $6.7B | $5.8B | ||
| Q2 24 | $6.6B | $5.7B | ||
| Q1 24 | $6.7B | $5.7B |
| Q4 25 | 14.31× | 0.19× | ||
| Q3 25 | 14.05× | — | ||
| Q2 25 | 15.48× | — | ||
| Q1 25 | 18.19× | — | ||
| Q4 24 | 20.26× | — | ||
| Q3 24 | 13.39× | — | ||
| Q2 24 | 11.26× | — | ||
| Q1 24 | 8.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | 3.5% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $417.3M | ||
| Q3 25 | $122.1M | $402.6M | ||
| Q2 25 | — | $263.6M | ||
| Q1 25 | $-60.2M | $44.1M | ||
| Q4 24 | $369.8M | $75.2M | ||
| Q3 24 | $58.4M | $188.4M | ||
| Q2 24 | $-66.1M | $-95.6M | ||
| Q1 24 | $63.9M | $-308.6M |
| Q4 25 | — | $379.8M | ||
| Q3 25 | $77.4M | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | $-119.1M | $-12.3M | ||
| Q4 24 | $307.2M | $-17.3M | ||
| Q3 24 | $7.4M | $54.7M | ||
| Q2 24 | $-122.8M | $-205.5M | ||
| Q1 24 | $11.7M | $-465.1M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | 5.8% | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | -9.6% | -1.1% | ||
| Q4 24 | 24.3% | -1.5% | ||
| Q3 24 | 0.6% | 5.5% | ||
| Q2 24 | -9.8% | -22.1% | ||
| Q1 24 | 0.9% | -61.9% |
| Q4 25 | 3.5% | 2.5% | ||
| Q3 25 | 3.3% | 3.4% | ||
| Q2 25 | 4.0% | 3.3% | ||
| Q1 25 | 4.7% | 5.0% | ||
| Q4 24 | 5.0% | 8.2% | ||
| Q3 24 | 4.1% | 13.3% | ||
| Q2 24 | 4.5% | 11.8% | ||
| Q1 24 | 4.2% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | 3.36× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | -1.17× | 34.71× | ||
| Q4 24 | 9.61× | — | ||
| Q3 24 | 2.02× | — | ||
| Q2 24 | -1.43× | — | ||
| Q1 24 | 1.30× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
